News and views
Read our latest news and updates.
For media inquiries, contact us at media@compasspathways.com
-
November 15, 2023
Compass Pathways initiates UK component of global phase 3 study of psilocybin treatment in treatment...
Read article
-
November 02, 2023
COMPASS Pathways Announces Third Quarter 2023 Financial Results and Business Highlights
Read article
-
October 26, 2023
Compass Pathways announces CFO transition
Read article
-
September 18, 2023
Compass Pathways appoints Daphne Karydas to its Board of Directors
Read article
-
September 06, 2023
Compass Pathways announces publication of first study evaluating potential of AI model to predict ou...
Read article
-
August 16, 2023
Compass Pathways Announces Up to $285 Million Private Placement Financing Joined by Leading Healthca...
Read article
-
August 03, 2023
Compass Pathways Announces Second Quarter 2023 Financial Results and Business Highlights
Read article
-
July 25, 2023
First clinical study results of psilocybin treatment in anorexia nervosa published in Nature Medicin...
Read article
-
July 17, 2023
Compass Pathways announces publication of positive data from treatment-resistant depression phase 2 ...
Read article
-
July 13, 2023
Opinion paper calls for clarity on the definition of “psychedelic-assisted therapy” using psiloc...
Read article
-
July 06, 2023
American Medical Association Releases Language of First New Current Procedural Terminology Code for ...
Read article
-
July 05, 2023
Compass Pathways Secures Term Loan Facility for Up to $50 Million from Hercules Capital
Read article
Looking for older news and views posts? View Compass news archive